References
- Basso C, Corrado D, Marcus FI, et al. Arrhythmogenic right ventricular cardiomyopathy. Lancet. 2009;373(9671):1289–1300.
- Basso C, Thiene G, Corrado D, et al. Congestive heart failure/valvular heart disease/transplantation: arrhythmogenic right ventricular cardiomyopathy: dysplasia, dystrophy, or myocarditis? Circulation. 1996;94(5):983–991.
- Haugaa KH, Haland TF, Leren IS, et al. Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis. Europace. 2016;18(7):965–972.
- Zorzi A, Rigato I, Bauce B, et al. Arrhythmogenic right ventricular cardiomyopathy: risk stratification and indications for defibrillator therapy. Curr Cardiol Rep. 2016;18(6):57.
- Philips B, Cheng A. Update on the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy. Curr Opin Cardiol. 2015;31(1):46–56. 2016.
- Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J. 2010;31(7):806–814.
- Agir A, Bozyel S, Celikyurt U, et al. Arrhythmogenic right ventricular cardiomyopathy in pregnancy. Int Heart J. 2014;55(4):372–376.
- Anouar J, Mohamed S, Kamel K. Management of a rare case of arrhythmogenic right ventricular dysplasia in pregnancy: a case report. Pan Afr Med J. 2014;19:1–4.
- Iriyama T, Kamei Y, Kozuma S, et al. Management of patient with arrhythmogenic right ventricular cardiomyopathy during pregnancy. J Obstet Gynaecol Res. 2013;39(1):390–394.
- Guducu N, Kutay SS, Ozenc E, et al. Management of a rare case of arrhythmogenic right ventricular dysplasia in pregnancy: a case report. J Med Case Rep. 2011;5:300.
- Bauce B, Daliento L, Frigo G, et al. Pregnancy in women with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Eur J Obstet Gynecol Reprod Biol. 2006;127(2):186–189.
- Doyle NM, Monga M, Montgomery B, et al. Arrhythmogenic right ventricular cardiomyopathy with implantable cardioverter defibrillator placement in pregnancy. J Matern Neonatal Med. 2005;18(2):141–144.
- Schiavone M, Calcagnino M, Mazzanti A, et al. Outcomes and management of arrhythmogenic right ventricular cardiomyopathy in pregnancy: a case report. Eur Hear J - Case Reports. 2019;3(4):1–5.
- Hodes AR, Tichnell C, Te Riele A, et al. Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy. Heart. 2016;102(4):303–312.
- Gandjbakhch E, Varlet E, Duthoit G, et al. Pregnancy and newborn outcomes in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Int J Cardiol. 2018;258:172–178.
- Wu L, Liang E, Fan S, et al. Effect of pregnancy in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol. 2020;125(4):613–617.
- Robson SC, Stewart H, Boys RJ, et al. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol. 1989;256(4):H1060–H1065.
- Ducas RA, Elliott JE, Melnyk SF, et al. Cardiovascular magnetic resonance in pregnancy: insights from the cardiac hemodynamic imaging and remodeling in pregnancy (CHIRP) study. J Cardiovasc Magn Reson. 2014;16(1):1.
- Zipes D, Camm A, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol. 2006;48(5):e247–e346.
- Cunningham FG, Leveno KJ, Blom SL, et al, eds. Williams Obstetrics. 24th ed. New York (NY): McGraw-Hill Education; 2014.
- Robertson CMT, Svenson LW, Kyle JM. Birth weight by gestational age for Albertan liveborn infants, 1985 through 1998. J Obstet Gynaecol Canada JOGC. 2002;24(2):138–148.
- Xie RH, Guo Y, Krewski D, et al. Beta-Blockers increase the risk of being born small for gestational age or of being institutionalised during infancy. BJOG Int J Obstet Gy. 2014;121(9):1090–1096.
- Heida KY, Zeeman GG, Van Veen TR, et al. Neonatal side effects of maternal labetalol treatment in severe preeclampsia. Early Hum Dev. 2012;88(7):503–507.
- Gupta RC, ed. Reproductive and developmental toxicology. 2nd ed. San Diego (CA): Academic Press; 2017.
- Castrini AI, Oyvind HL, Leren IS, et al. Number of pregnancies and subsequent phenotype in a cross-sectional cohort of women with arrhythmogenic cardiomyopathy. Eur Heart J-Cardiovasc Imaging. 2019;20(2):192–198.